PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
NCT ID: NCT04889872
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
2250 participants
INTERVENTIONAL
2021-10-12
2037-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAVR
Transcatheter Aortic Valve Replacement (TAVR)
SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA
Patients will be implanted with a SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA heart valve
CS
Clinical Surveillance (CS)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA
Patients will be implanted with a SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA heart valve
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Moderate aortic stenosis
3. Subject has symptoms or evidence of cardiac damage/dysfunction
4. The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent.
Exclusion Criteria
2. Anatomical characteristics that would preclude safe transfemoral placement of the introducer sheath or safe passage of the delivery system
3. Aortic valve is unicuspid or non-calcified
4. Bicuspid aortic valve with an aneurysmal ascending aorta \> 4.5 cm or severe raphe/leaflet calcification
5. Pre-existing mechanical or bioprosthetic aortic valve
6. Severe aortic regurgitation
7. Prior balloon aortic valvuloplasty to treat severe AS
8. LVEF \< 20%
9. Left ventricular outflow tract calcification that would increase the risk of annular rupture or significant paravalvular leak post-TAVR
10. Cardiac imaging evidence of intracardiac mass, thrombus, or vegetation
11. Coronary or aortic valve anatomy that increases the risk of coronary artery obstruction post-TAVR
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Généreux, MD
Role: PRINCIPAL_INVESTIGATOR
Morristown Medical Center, Morristown, NJ, USA
Jeroen J Bax, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Leiden University Medical Center, Leiden, The Netherlands
Raj Makkar, MD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Center LLC, Huntsville
Huntsville, Alabama, United States
Tucson Medical Center
Tucson, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Huntington Hospital
Pasadena, California, United States
Eisenhower Desert Cardiology Center
Rancho Mirage, California, United States
Bay Area Structural Heart at Sutter Health
San Francisco, California, United States
Kaiser San Francisco Medical Center
San Francisco, California, United States
University of California San Francisco
San Francisco, California, United States
Santa Barbara Cottage Hospital
Santa Barbara, California, United States
Stanford Univeristy
Stanford, California, United States
UC Health Medical Center of the Rockies
Loveland, Colorado, United States
Yale Universtiy
New Haven, Connecticut, United States
The Cardiac & Vascular Institute Research Foundation
Gainesville, Florida, United States
Baptist Health Research Center
Jacksonville, Florida, United States
Sarasota Memorial Health Care System
Sarasota, Florida, United States
Emory University Atlanta
Atlanta, Georgia, United States
Piedmont Heart Institute
Atlanta, Georgia, United States
Saint Alphonsus
Boise, Idaho, United States
Rush University Medical Center
Chicago, Illinois, United States
Alexian Brothers Hospital
Lisle, Illinois, United States
Ascension Via Christi St. Francis
Wichita, Kansas, United States
Louisiana State University
New Orleans, Louisiana, United States
Ochsner Clinical Foundation
New Orleans, Louisiana, United States
Massachusetts General Hospital Boston
Boston, Massachusetts, United States
Minneapolis Heart Institue, St. Paul's
Minneapolis, Minnesota, United States
CentraCare Heart and Vascular Center
Saint Cloud, Minnesota, United States
Saint Luke's Hospital of Kansas City Mid America
Kansas City, Missouri, United States
St. Patrick Hospital
Missoula, Montana, United States
Mary Hitchcock Memorial Hospital
Lebanon, New Hampshire, United States
Atlantic Health System Hospital Corp - Morristown Medical Center
Morristown, New Jersey, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
The Valley Hospital
Ridgewood, New Jersey, United States
University of Buffalo Kaleida Health
Buffalo, New York, United States
NYU Langone Hospital - Long Island
Mineola, New York, United States
NYU Langone Health
New York, New York, United States
Columbia University Irving Medical Center/NYPH
New York, New York, United States
Rochester General Hospital
Rochester, New York, United States
St. Francis Hospital
Roslyn, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Moses Cone Memorial Hospital
Greensboro, North Carolina, United States
The Christ Hospital
Cincinnati, Ohio, United States
Mount Carmel Health System
Columbus, Ohio, United States
Oklahoma Heart Institute
Tulsa, Oklahoma, United States
Kaiser Permanente Northwest
Clackamas, Oregon, United States
Providence Heart & Vascular Institute Portland
Portland, Oregon, United States
Legacy Emanuel Medical Center
Portland, Oregon, United States
Allegheny Singer Research Institute
Pittsburgh, Pennsylvania, United States
UPMC Presbyterian Shadyside
Pittsburgh, Pennsylvania, United States
Pinnacle Health Harrisburg
Wormleysburg, Pennsylvania, United States
Lankenau Medical Center
Wynnewood, Pennsylvania, United States
Baptist Memorial Hospital Memphis
Germantown, Tennessee, United States
Methodist Le Bonheur Healthcare
Germantown, Tennessee, United States
Parkwest Medical Center
Knoxville, Tennessee, United States
Saint Thomas Health
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Ascension Texas Cardiovascular
Austin, Texas, United States
UT Southwestern Medical Center
Dallas, Texas, United States
HCA Houston Healthcare Medical Center
Houston, Texas, United States
The University of Texas Health Science Center
Houston, Texas, United States
The Heart Hospital Baylor Plano
Plano, Texas, United States
Methodist Hospital of San Antonio
San Antonio, Texas, United States
Kaiser Mid Atlantic
McLean, Virginia, United States
Sentara Norfolk General Hospital
Norfolk, Virginia, United States
Swedish Medical Center
Seattle, Washington, United States
The Prince Charles Hospital
Chermside, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Monash Health
Clayton, Victoria, Australia
St. Paul's Hospital
Vancouver, British Columbia, Canada
Hamiton Health Services
Hamilton, Onterio, Canada
Kokura Memorial Hospital
Fukuoka, Kyushu, Japan
Sendai Kousei Hospital
Sendai, Miyagi, Japan
Sakakibara Heart Institute
Fuchū, Tokyo, Japan
Keio University Hospital
Shinjuku, Tokyo, Japan
AMC Amsterdam
Amsterdam, North Holland, Netherlands
Leiden Universitair Medisch Centrum
Leiden, South Holland, Netherlands
Erasmus Rotterdam
Rotterdam, South Holland, Netherlands
Hôpitaux Universitaire de Genève
Geneva, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-01
Identifier Type: -
Identifier Source: org_study_id